2013 Board of Directors Election
The Cancer Cytogenomics Microarray Consortium 2013 Board of Directors Election is now open through May 20, 2013, 11:59 PM Central Daylight Time, USA.
To cast your vote, please login with your CCMC Username and Pasword before you click the link on the right
CCMC/CAGdb 2013 Meeting
August 5-7, 2013 | Swissotel, Chicago
Regular Registration Rate for the Meeting ends on July 9th, 2013
Hotel Reservation at Member Discount Rate ends on July 9th, 2013
The Cancer Cytogenomics Microarray Consortium (CCMC) has scheduled its 4th summer meeting which will be held in conjunction with the Cytogenomics Array Group (CAGdb) meeting. The joint conference will be held at the Swissotel in Downtown Chicago on August 5-7, 2013.
Title: Evolving technologies for cancer diagnostics
Timothy J. Ley, M.D.
Washington University in St. Louis
The first half of the meeting will be devoted to cancer-related topics and will include invited presentations from leading cancer geneticists/genomicists, focusing on the clinically important as well as recent developments in cancer genomic diagnosis, prognosis, and management. The Key Note Address entitled “Evolving technologies for cancer diagnostics” will be delivered by Dr. Timothy Ley from the Genome Institute at Washington University. Dr. Ley is a hematologist, oncologist & cancer biologist and is internationally recognized as an expert in the pathogenesis of acute myeloid leukemia (AML) and other blood-related disorders.
Title: Constitutional Array CGH: Looking Back and Looking Ahead
David Miller, M.D., Ph.D.
The second half of the meeting will focus on constitutional microarray analysis with various workshops planned for data interpretation, information sharing, database building and best practices in reporting and follow-up. Dr. David Miller from Boston Children’s Hospital will give the Key Note Address entitled “Constitutional Array CGH: Looking Back and Looking Ahead”. Dr. Miller is a medical geneticist and clinical molecular geneticist and an Assistant Professor of Pediatrics at Harvard Medical School. Dr. Miller has authored several key publications in the field of medical genetics and genetic testing, more recently focusing on the clinical value and utility of genetic testing.
The mid-portion of the meeting (afternoon of Day 2) will cover practical topics that relate to both cancer and constitutional diagnostics such as microarray data quality metrics.
Additionally, we are providing an optional short workshop at the end of the meeting for any attendees new to microarray analysis or desiring a hands-on interactive session for microarray interpretation. During this 2 ½ hour final session, we will review useful databases and provide hands-on demonstrations for microarray interpretations. Prior to the meeting, we will poll attendees for interest and desired topic coverage for this session.
Abstracts will only be presented in the first half of the meeting and therefore submissions should focus on cancer-related topics. The deadline for abstract submission is April 22nd, 2013. All abstracts will be published in the journal Cancer Genetics.
We look forward to seeing you in Chicago.
On Behalf of CCMC/CAGdb Program Committee
Brynn Levy, M.Sc. (Med),Ph.D
Hutton Kearney, Ph.D – Founder CAGdb
Our sponsors (Arranged in Alphabetical Order)